Gilead Sciences will pay approximately $1.5 billion in cash as an upfront payment to investors of the privately held company Ouro.

老虎证券2026/03/23 17:00

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

In addition, Gilead Sciences will pay at least $500 million more if certain clinical trial milestones are met. This deal structure highlights the trend of high valuations for innovative therapies in the biopharmaceutical industry, and the model of tying payments closely to R&D progress has become a new feature of current M&A transactions.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gilead Sciences will pay approximately $1.5 billion in cash as an upfront payment to investors of the privately held company Ouro.

You may also like

Crypto prices